Request for Covid-19 Impact Assessment of this Report
The United States OTC Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global OTC Drug market, reaching US$ million by the year 2028. As for the Europe OTC Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main OTC Drug players cover Bayer HealthCare, GlaxoSmithKline(GSK), Johnson&Johnson, and Pfizer, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of OTC Drug market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Class A OTC Drug
Class B OTC Drug
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospital
Clinic
Household
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Bayer HealthCare
GlaxoSmithKline(GSK)
Johnson&Johnson
Pfizer
Sanofi
AstraZeneca
BioGaia
Bristol Myers Squibb
Bukwang Pharmaceutica
Chr. Hansen
Cipla
CoLucid
Daiichi Sankyo
Friggs
DSM
Eisai
Eli Lilly
Herbalife
Euradite
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global OTC Drug Market Size 2017-2028
2.1.2 OTC Drug Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 OTC Drug Segment by Type
2.2.1 Class A OTC Drug
2.2.2 Class B OTC Drug
2.3 OTC Drug Market Size by Type
2.3.1 OTC Drug Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global OTC Drug Market Size Market Share by Type (2017-2022)
2.4 OTC Drug Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Household
2.5 OTC Drug Market Size by Application
2.5.1 OTC Drug Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global OTC Drug Market Size Market Share by Application (2017-2022)
3 OTC Drug Market Size by Player
3.1 OTC Drug Market Size Market Share by Players
3.1.1 Global OTC Drug Revenue by Players (2020-2022)
3.1.2 Global OTC Drug Revenue Market Share by Players (2020-2022)
3.2 Global OTC Drug Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 OTC Drug by Regions
4.1 OTC Drug Market Size by Regions (2017-2022)
4.2 Americas OTC Drug Market Size Growth (2017-2022)
4.3 APAC OTC Drug Market Size Growth (2017-2022)
4.4 Europe OTC Drug Market Size Growth (2017-2022)
4.5 Middle East & Africa OTC Drug Market Size Growth (2017-2022)
5 Americas
5.1 Americas OTC Drug Market Size by Country (2017-2022)
5.2 Americas OTC Drug Market Size by Type (2017-2022)
5.3 Americas OTC Drug Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC OTC Drug Market Size by Region (2017-2022)
6.2 APAC OTC Drug Market Size by Type (2017-2022)
6.3 APAC OTC Drug Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe OTC Drug by Country (2017-2022)
7.2 Europe OTC Drug Market Size by Type (2017-2022)
7.3 Europe OTC Drug Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa OTC Drug by Region (2017-2022)
8.2 Middle East & Africa OTC Drug Market Size by Type (2017-2022)
8.3 Middle East & Africa OTC Drug Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global OTC Drug Market Forecast
10.1 Global OTC Drug Forecast by Regions (2023-2028)
10.1.1 Global OTC Drug Forecast by Regions (2023-2028)
10.1.2 Americas OTC Drug Forecast
10.1.3 APAC OTC Drug Forecast
10.1.4 Europe OTC Drug Forecast
10.1.5 Middle East & Africa OTC Drug Forecast
10.2 Americas OTC Drug Forecast by Country (2023-2028)
10.2.1 United States OTC Drug Market Forecast
10.2.2 Canada OTC Drug Market Forecast
10.2.3 Mexico OTC Drug Market Forecast
10.2.4 Brazil OTC Drug Market Forecast
10.3 APAC OTC Drug Forecast by Region (2023-2028)
10.3.1 China OTC Drug Market Forecast
10.3.2 Japan OTC Drug Market Forecast
10.3.3 Korea OTC Drug Market Forecast
10.3.4 Southeast Asia OTC Drug Market Forecast
10.3.5 India OTC Drug Market Forecast
10.3.6 Australia OTC Drug Market Forecast
10.4 Europe OTC Drug Forecast by Country (2023-2028)
10.4.1 Germany OTC Drug Market Forecast
10.4.2 France OTC Drug Market Forecast
10.4.3 UK OTC Drug Market Forecast
10.4.4 Italy OTC Drug Market Forecast
10.4.5 Russia OTC Drug Market Forecast
10.5 Middle East & Africa OTC Drug Forecast by Region (2023-2028)
10.5.1 Egypt OTC Drug Market Forecast
10.5.2 South Africa OTC Drug Market Forecast
10.5.3 Israel OTC Drug Market Forecast
10.5.4 Turkey OTC Drug Market Forecast
10.5.5 GCC Countries OTC Drug Market Forecast
10.6 Global OTC Drug Forecast by Type (2023-2028)
10.7 Global OTC Drug Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Bayer HealthCare
11.1.1 Bayer HealthCare Company Information
11.1.2 Bayer HealthCare OTC Drug Product Offered
11.1.3 Bayer HealthCare OTC Drug Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Bayer HealthCare Main Business Overview
11.1.5 Bayer HealthCare Latest Developments
11.2 GlaxoSmithKline(GSK)
11.2.1 GlaxoSmithKline(GSK) Company Information
11.2.2 GlaxoSmithKline(GSK) OTC Drug Product Offered
11.2.3 GlaxoSmithKline(GSK) OTC Drug Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 GlaxoSmithKline(GSK) Main Business Overview
11.2.5 GlaxoSmithKline(GSK) Latest Developments
11.3 Johnson&Johnson
11.3.1 Johnson&Johnson Company Information
11.3.2 Johnson&Johnson OTC Drug Product Offered
11.3.3 Johnson&Johnson OTC Drug Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Johnson&Johnson Main Business Overview
11.3.5 Johnson&Johnson Latest Developments
11.4 Pfizer
11.4.1 Pfizer Company Information
11.4.2 Pfizer OTC Drug Product Offered
11.4.3 Pfizer OTC Drug Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Pfizer Main Business Overview
11.4.5 Pfizer Latest Developments
11.5 Sanofi
11.5.1 Sanofi Company Information
11.5.2 Sanofi OTC Drug Product Offered
11.5.3 Sanofi OTC Drug Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Sanofi Main Business Overview
11.5.5 Sanofi Latest Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Information
11.6.2 AstraZeneca OTC Drug Product Offered
11.6.3 AstraZeneca OTC Drug Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 AstraZeneca Main Business Overview
11.6.5 AstraZeneca Latest Developments
11.7 BioGaia
11.7.1 BioGaia Company Information
11.7.2 BioGaia OTC Drug Product Offered
11.7.3 BioGaia OTC Drug Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 BioGaia Main Business Overview
11.7.5 BioGaia Latest Developments
11.8 Bristol Myers Squibb
11.8.1 Bristol Myers Squibb Company Information
11.8.2 Bristol Myers Squibb OTC Drug Product Offered
11.8.3 Bristol Myers Squibb OTC Drug Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Bristol Myers Squibb Main Business Overview
11.8.5 Bristol Myers Squibb Latest Developments
11.9 Bukwang Pharmaceutica
11.9.1 Bukwang Pharmaceutica Company Information
11.9.2 Bukwang Pharmaceutica OTC Drug Product Offered
11.9.3 Bukwang Pharmaceutica OTC Drug Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Bukwang Pharmaceutica Main Business Overview
11.9.5 Bukwang Pharmaceutica Latest Developments
11.10 Chr. Hansen
11.10.1 Chr. Hansen Company Information
11.10.2 Chr. Hansen OTC Drug Product Offered
11.10.3 Chr. Hansen OTC Drug Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Chr. Hansen Main Business Overview
11.10.5 Chr. Hansen Latest Developments
11. Cipla
11.11.1 Cipla Company Information
11.11.2 Cipla OTC Drug Product Offered
11.11.3 Cipla OTC Drug Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Cipla Main Business Overview
11.11.5 Cipla Latest Developments
11.12 CoLucid
11.12.1 CoLucid Company Information
11.12.2 CoLucid OTC Drug Product Offered
11.12.3 CoLucid OTC Drug Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 CoLucid Main Business Overview
11.12.5 CoLucid Latest Developments
11.13 Daiichi Sankyo
11.13.1 Daiichi Sankyo Company Information
11.13.2 Daiichi Sankyo OTC Drug Product Offered
11.13.3 Daiichi Sankyo OTC Drug Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Daiichi Sankyo Main Business Overview
11.13.5 Daiichi Sankyo Latest Developments
11.14 Friggs
11.14.1 Friggs Company Information
11.14.2 Friggs OTC Drug Product Offered
11.14.3 Friggs OTC Drug Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Friggs Main Business Overview
11.14.5 Friggs Latest Developments
11.15 DSM
11.15.1 DSM Company Information
11.15.2 DSM OTC Drug Product Offered
11.15.3 DSM OTC Drug Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 DSM Main Business Overview
11.15.5 DSM Latest Developments
11.16 Eisai
11.16.1 Eisai Company Information
11.16.2 Eisai OTC Drug Product Offered
11.16.3 Eisai OTC Drug Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 Eisai Main Business Overview
11.16.5 Eisai Latest Developments
11.17 Eli Lilly
11.17.1 Eli Lilly Company Information
11.17.2 Eli Lilly OTC Drug Product Offered
11.17.3 Eli Lilly OTC Drug Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 Eli Lilly Main Business Overview
11.17.5 Eli Lilly Latest Developments
11.18 Herbalife
11.18.1 Herbalife Company Information
11.18.2 Herbalife OTC Drug Product Offered
11.18.3 Herbalife OTC Drug Revenue, Gross Margin and Market Share (2020-2022)
11.18.4 Herbalife Main Business Overview
11.18.5 Herbalife Latest Developments
11.19 Euradite
11.19.1 Euradite Company Information
11.19.2 Euradite OTC Drug Product Offered
11.19.3 Euradite OTC Drug Revenue, Gross Margin and Market Share (2020-2022)
11.19.4 Euradite Main Business Overview
11.19.5 Euradite Latest Developments
12 Research Findings and Conclusion
Table 1. OTC Drug Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Class A OTC Drug
Table 3. Major Players of Class B OTC Drug
Table 4. OTC Drug Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global OTC Drug Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global OTC Drug Market Size Market Share by Type (2017-2022)
Table 7. OTC Drug Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global OTC Drug Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global OTC Drug Market Size Market Share by Application (2017-2022)
Table 10. Global OTC Drug Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global OTC Drug Revenue Market Share by Player (2020-2022)
Table 12. OTC Drug Key Players Head office and Products Offered
Table 13. OTC Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global OTC Drug Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global OTC Drug Market Size Market Share by Regions (2017-2022)
Table 18. Americas OTC Drug Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas OTC Drug Market Size Market Share by Country (2017-2022)
Table 20. Americas OTC Drug Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas OTC Drug Market Size Market Share by Type (2017-2022)
Table 22. Americas OTC Drug Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas OTC Drug Market Size Market Share by Application (2017-2022)
Table 24. APAC OTC Drug Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC OTC Drug Market Size Market Share by Region (2017-2022)
Table 26. APAC OTC Drug Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC OTC Drug Market Size Market Share by Type (2017-2022)
Table 28. APAC OTC Drug Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC OTC Drug Market Size Market Share by Application (2017-2022)
Table 30. Europe OTC Drug Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe OTC Drug Market Size Market Share by Country (2017-2022)
Table 32. Europe OTC Drug Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe OTC Drug Market Size Market Share by Type (2017-2022)
Table 34. Europe OTC Drug Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe OTC Drug Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa OTC Drug Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa OTC Drug Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa OTC Drug Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa OTC Drug Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa OTC Drug Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa OTC Drug Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of OTC Drug
Table 43. Key Market Challenges & Risks of OTC Drug
Table 44. Key Industry Trends of OTC Drug
Table 45. Global OTC Drug Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global OTC Drug Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global OTC Drug Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global OTC Drug Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global OTC Drug Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global OTC Drug Market Size Market Share Forecast by Application (2023-2028)
Table 51. Bayer HealthCare Details, Company Type, OTC Drug Area Served and Its Competitors
Table 52. Bayer HealthCare OTC Drug Product Offered
Table 53. Bayer HealthCare OTC Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Bayer HealthCare Main Business
Table 55. Bayer HealthCare Latest Developments
Table 56. GlaxoSmithKline(GSK) Details, Company Type, OTC Drug Area Served and Its Competitors
Table 57. GlaxoSmithKline(GSK) OTC Drug Product Offered
Table 58. GlaxoSmithKline(GSK) Main Business
Table 59. GlaxoSmithKline(GSK) OTC Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. GlaxoSmithKline(GSK) Latest Developments
Table 61. Johnson&Johnson Details, Company Type, OTC Drug Area Served and Its Competitors
Table 62. Johnson&Johnson OTC Drug Product Offered
Table 63. Johnson&Johnson Main Business
Table 64. Johnson&Johnson OTC Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Johnson&Johnson Latest Developments
Table 66. Pfizer Details, Company Type, OTC Drug Area Served and Its Competitors
Table 67. Pfizer OTC Drug Product Offered
Table 68. Pfizer Main Business
Table 69. Pfizer OTC Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Pfizer Latest Developments
Table 71. Sanofi Details, Company Type, OTC Drug Area Served and Its Competitors
Table 72. Sanofi OTC Drug Product Offered
Table 73. Sanofi Main Business
Table 74. Sanofi OTC Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Sanofi Latest Developments
Table 76. AstraZeneca Details, Company Type, OTC Drug Area Served and Its Competitors
Table 77. AstraZeneca OTC Drug Product Offered
Table 78. AstraZeneca Main Business
Table 79. AstraZeneca OTC Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. AstraZeneca Latest Developments
Table 81. BioGaia Details, Company Type, OTC Drug Area Served and Its Competitors
Table 82. BioGaia OTC Drug Product Offered
Table 83. BioGaia Main Business
Table 84. BioGaia OTC Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. BioGaia Latest Developments
Table 86. Bristol Myers Squibb Details, Company Type, OTC Drug Area Served and Its Competitors
Table 87. Bristol Myers Squibb OTC Drug Product Offered
Table 88. Bristol Myers Squibb Main Business
Table 89. Bristol Myers Squibb OTC Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Bristol Myers Squibb Latest Developments
Table 91. Bukwang Pharmaceutica Details, Company Type, OTC Drug Area Served and Its Competitors
Table 92. Bukwang Pharmaceutica OTC Drug Product Offered
Table 93. Bukwang Pharmaceutica Main Business
Table 94. Bukwang Pharmaceutica OTC Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Bukwang Pharmaceutica Latest Developments
Table 96. Chr. Hansen Details, Company Type, OTC Drug Area Served and Its Competitors
Table 97. Chr. Hansen OTC Drug Product Offered
Table 98. Chr. Hansen Main Business
Table 99. Chr. Hansen OTC Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. Chr. Hansen Latest Developments
Table 101. Cipla Details, Company Type, OTC Drug Area Served and Its Competitors
Table 102. Cipla OTC Drug Product Offered
Table 103. Cipla OTC Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 104. Cipla Main Business
Table 105. Cipla Latest Developments
Table 106. CoLucid Details, Company Type, OTC Drug Area Served and Its Competitors
Table 107. CoLucid OTC Drug Product Offered
Table 108. CoLucid Main Business
Table 109. CoLucid OTC Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 110. CoLucid Latest Developments
Table 111. Daiichi Sankyo Details, Company Type, OTC Drug Area Served and Its Competitors
Table 112. Daiichi Sankyo OTC Drug Product Offered
Table 113. Daiichi Sankyo Main Business
Table 114. Daiichi Sankyo OTC Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 115. Daiichi Sankyo Latest Developments
Table 116. Friggs Details, Company Type, OTC Drug Area Served and Its Competitors
Table 117. Friggs OTC Drug Product Offered
Table 118. Friggs Main Business
Table 119. Friggs OTC Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 120. Friggs Latest Developments
Table 121. DSM Details, Company Type, OTC Drug Area Served and Its Competitors
Table 122. DSM OTC Drug Product Offered
Table 123. DSM Main Business
Table 124. DSM OTC Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 125. DSM Latest Developments
Table 126. Eisai Details, Company Type, OTC Drug Area Served and Its Competitors
Table 127. Eisai OTC Drug Product Offered
Table 128. Eisai Main Business
Table 129. Eisai OTC Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 130. Eisai Latest Developments
Table 131. Eli Lilly Details, Company Type, OTC Drug Area Served and Its Competitors
Table 132. Eli Lilly OTC Drug Product Offered
Table 133. Eli Lilly Main Business
Table 134. Eli Lilly OTC Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 135. Eli Lilly Latest Developments
Table 136. Herbalife Details, Company Type, OTC Drug Area Served and Its Competitors
Table 137. Herbalife OTC Drug Product Offered
Table 138. Herbalife Main Business
Table 139. Herbalife OTC Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 140. Herbalife Latest Developments
Table 141. Euradite Details, Company Type, OTC Drug Area Served and Its Competitors
Table 142. Euradite OTC Drug Product Offered
Table 143. Euradite Main Business
Table 144. Euradite OTC Drug Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 145. Euradite Latest Developments
List of Figures
Figure 1. OTC Drug Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global OTC Drug Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global OTC Drug Market Size Market Share by Type in 2021
Figure 7. OTC Drug in Hospital
Figure 8. Global OTC Drug Market: Hospital (2017-2022) & ($ Millions)
Figure 9. OTC Drug in Clinic
Figure 10. Global OTC Drug Market: Clinic (2017-2022) & ($ Millions)
Figure 11. OTC Drug in Household
Figure 12. Global OTC Drug Market: Household (2017-2022) & ($ Millions)
Figure 13. Global OTC Drug Market Size Market Share by Application in 2021
Figure 14. Global OTC Drug Revenue Market Share by Player in 2021
Figure 15. Global OTC Drug Market Size Market Share by Regions (2017-2022)
Figure 16. Americas OTC Drug Market Size 2017-2022 ($ Millions)
Figure 17. APAC OTC Drug Market Size 2017-2022 ($ Millions)
Figure 18. Europe OTC Drug Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa OTC Drug Market Size 2017-2022 ($ Millions)
Figure 20. Americas OTC Drug Value Market Share by Country in 2021
Figure 21. Americas OTC Drug Consumption Market Share by Type in 2021
Figure 22. Americas OTC Drug Market Size Market Share by Application in 2021
Figure 23. United States OTC Drug Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada OTC Drug Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico OTC Drug Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil OTC Drug Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC OTC Drug Market Size Market Share by Region in 2021
Figure 28. APAC OTC Drug Market Size Market Share by Application in 2021
Figure 29. China OTC Drug Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan OTC Drug Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea OTC Drug Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia OTC Drug Market Size Growth 2017-2022 ($ Millions)
Figure 33. India OTC Drug Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia OTC Drug Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe OTC Drug Market Size Market Share by Country in 2021
Figure 36. Europe OTC Drug Market Size Market Share by Type in 2021
Figure 37. Europe OTC Drug Market Size Market Share by Application in 2021
Figure 38. Germany OTC Drug Market Size Growth 2017-2022 ($ Millions)
Figure 39. France OTC Drug Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK OTC Drug Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy OTC Drug Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia OTC Drug Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa OTC Drug Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa OTC Drug Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa OTC Drug Market Size Market Share by Application in 2021
Figure 46. Egypt OTC Drug Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa OTC Drug Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel OTC Drug Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey OTC Drug Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country OTC Drug Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas OTC Drug Market Size 2023-2028 ($ Millions)
Figure 52. APAC OTC Drug Market Size 2023-2028 ($ Millions)
Figure 53. Europe OTC Drug Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa OTC Drug Market Size 2023-2028 ($ Millions)
Figure 55. United States OTC Drug Market Size 2023-2028 ($ Millions)
Figure 56. Canada OTC Drug Market Size 2023-2028 ($ Millions)
Figure 57. Mexico OTC Drug Market Size 2023-2028 ($ Millions)
Figure 58. Brazil OTC Drug Market Size 2023-2028 ($ Millions)
Figure 59. China OTC Drug Market Size 2023-2028 ($ Millions)
Figure 60. Japan OTC Drug Market Size 2023-2028 ($ Millions)
Figure 61. Korea OTC Drug Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia OTC Drug Market Size 2023-2028 ($ Millions)
Figure 63. India OTC Drug Market Size 2023-2028 ($ Millions)
Figure 64. Australia OTC Drug Market Size 2023-2028 ($ Millions)
Figure 65. Germany OTC Drug Market Size 2023-2028 ($ Millions)
Figure 66. France OTC Drug Market Size 2023-2028 ($ Millions)
Figure 67. UK OTC Drug Market Size 2023-2028 ($ Millions)
Figure 68. Italy OTC Drug Market Size 2023-2028 ($ Millions)
Figure 69. Russia OTC Drug Market Size 2023-2028 ($ Millions)
Figure 70. Spain OTC Drug Market Size 2023-2028 ($ Millions)
Figure 71. Egypt OTC Drug Market Size 2023-2028 ($ Millions)
Figure 72. South Africa OTC Drug Market Size 2023-2028 ($ Millions)
Figure 73. Israel OTC Drug Market Size 2023-2028 ($ Millions)
Figure 74. Turkey OTC Drug Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries OTC Drug Market Size 2023-2028 ($ Millions)
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...